6K9U
Discovery of Pyrazolo[1,5-a]pyrimidine Derivative as a Highly Selective PDE10A Inhibitor
Summary for 6K9U
Entry DOI | 10.2210/pdb6k9u/pdb |
Descriptor | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A, ZINC ION, MAGNESIUM ION, ... (6 entities in total) |
Functional Keywords | enzyme, pde, bbb, brain penetration, crystatl structure, inhibitor, schizophrenia, hydrolase |
Biological source | Rattus norvegicus (Rat) |
Total number of polymer chains | 1 |
Total formula weight | 36543.61 |
Authors | Takedomi, K.,Koizumi, Y. (deposition date: 2019-06-18, release date: 2019-07-17, Last modification date: 2024-03-27) |
Primary citation | Koizumi, Y.,Tanaka, Y.,Matsumura, T.,Kadoh, Y.,Miyoshi, H.,Hongu, M.,Takedomi, K.,Kotera, J.,Sasaki, T.,Taniguchi, H.,Watanabe, Y.,Takakuwa, M.,Kojima, K.,Baba, N.,Nakamura, I.,Kawanishi, E. Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moiety. Bioorg.Med.Chem., 27:3440-3450, 2019 Cited by PubMed: 31235264DOI: 10.1016/j.bmc.2019.06.021 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.35 Å) |
Structure validation
Download full validation report